Cargando…
Corticosteroid use in chronic dermatologic disorders and osteoporosis
Glucocorticoid-induced osteoporosis (GIOP) is a frequently encountered and serious side effect of glucocorticoid use. Bone loss leading to an increased risk for fracture occurs early in the use of glucocorticoids, yet patients at risk for this complication are often undertreated. All physicians pres...
Autores principales: | Lupsa, Beatrice C., Insogna, Karl L., Micheletti, Robert G., Caplan, Avrom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721058/ https://www.ncbi.nlm.nih.gov/pubmed/35024411 http://dx.doi.org/10.1016/j.ijwd.2021.07.014 |
Ejemplares similares
-
Advances in cutaneous vasculitis research and clinical care
por: Caplan, Avrom, et al.
Publicado: (2021) -
Asthma and Therapeutics: Inhaled Corticosteroids, Corticosteroid Osteoporosis, and the Risk of Fracture in Chronic Asthma
por: Toogood, John H
Publicado: (2005) -
Use of Topical Corticosteroids in Dermatology: An Evidence-based Approach
por: Das, Anupam, et al.
Publicado: (2017) -
Urticarial dermatitis herpetiformis: A rare presentation of an uncommon disorder
por: Sally, Rachel, et al.
Publicado: (2022) -
A Treatise on Topical Corticosteroid in Dermatology
por: Sarkar, Somenath
Publicado: (2018)